CLDN1 and serum lipopolysaccharide activity: Although BFT has neither been shown to alter the fecal mucin level nor to alter the amount of bacterial metabolites, such as short-chain fatty acids, it increased tight-junction-related protein claudin 1 level in the colon, leading to improved gut permeability and attenuated endotoxemia.